32 related articles for article (PubMed ID: 16176689)
1. Influence of TGFB1 and CTLA4 polymorphisms on calcineurin inhibitors dose and risk of acute rejection in renal transplantation.
Bogacz A; Wolek M; Sieńko J; Czerny B; Machaliński B; Olbromski P; Kotowski M
Sci Rep; 2021 Sep; 11(1):17531. PubMed ID: 34475433
[TBL] [Abstract][Full Text] [Related]
2. Non-HLA Genetic Factors and Their Influence on Heart Transplant Outcomes: A Systematic Review.
van Setten J; Warmerdam EG; Groot OQ; de Jonge N; Keating B; Asselbergs FW
Transplant Direct; 2019 Feb; 5(2):e422. PubMed ID: 30882026
[TBL] [Abstract][Full Text] [Related]
3. Combined effects of TGFB1 +869 T/C and +915 G/C polymorphisms on acute rejection risk in solid organ transplant recipients: a systematic review and meta-analysis.
Ge YZ; Wu R; Lu TZ; Jia RP; Li MH; Gao XF; Jiang XM; Zhu XB; Li LP; Tan SJ; Song Q; Li WC; Zhu JG
PLoS One; 2014; 9(4):e93938. PubMed ID: 24705444
[TBL] [Abstract][Full Text] [Related]
4. The functional class evaluated in rheumatoid arthritis is associated with soluble TGF-β1 serum levels but not with G915C (Arg25Pro) TGF-β1 polymorphism.
Muñoz-Valle JF; Torres-Carrillo NM; Guzmán-Guzmán IP; Torres-Carrillo N; Ruiz-Quezada SL; Palafox-Sánchez CA; Rangel-Villalobos H; Ramírez-Dueñas MG; Parra-Rojas I; Fafutis-Morris M; Bastidas-Ramírez BE; Pereira-Suárez AL
Rheumatol Int; 2012 Feb; 32(2):367-72. PubMed ID: 21113716
[TBL] [Abstract][Full Text] [Related]
5. Endothelin-mediated oncofetal fibronectin expression in chronic allograft nephropathy.
Siddiqui I; Khan ZA; Lian D; Jiang J; Zhong R; Garcia B; Chakrabarti S
Transplantation; 2006 Aug; 82(3):406-14. PubMed ID: 16906041
[TBL] [Abstract][Full Text] [Related]
6. Association of C-509T and T869C polymorphisms of transforming growth factor-beta1 gene with chronic allograft nephropathy and graft survival in Korean renal transplant recipients.
Cho JH; Huh S; Kwon TG; Choi JY; Hur IK; Lee EY; Park SH; Kim YL; Kim CD
Transplant Proc; 2008 Sep; 40(7):2355-60. PubMed ID: 18790234
[TBL] [Abstract][Full Text] [Related]
7. Cytokine gene polymorphism in kidney transplantation--impact of TGF-beta 1, TNF-alpha and IL-6 on graft outcome.
Nikolova PN; Ivanova MI; Mihailova SM; Myhailova AP; Baltadjieva DN; Simeonov PL; Paskalev EK; Naumova EJ
Transpl Immunol; 2008 Feb; 18(4):344-8. PubMed ID: 18158121
[TBL] [Abstract][Full Text] [Related]
8. TGF-beta1 in chronic allograft nephropathy following renal transplantation.
Harris S; Coupes BM; Roberts SA; Roberts IS; Short CD; Brenchley PE
J Nephrol; 2007; 20(2):177-85. PubMed ID: 17514622
[TBL] [Abstract][Full Text] [Related]
9. TGFbeta-1 and the development of chronic graft nephropathy: relative roles of gene, mRNA and protein.
Morris-Stiff G
Ann R Coll Surg Engl; 2005 Sep; 87(5):326-30. PubMed ID: 16176689
[TBL] [Abstract][Full Text] [Related]
10. [Transforming growth factor (TGF-beta) and kidney transplantation].
Matl I; Viklický O
Cas Lek Cesk; 2002 Sep; 141(19):601-4. PubMed ID: 12501502
[TBL] [Abstract][Full Text] [Related]
11. Transforming growth factor beta (TGFbeta) and keloid disease.
Jagadeesan J; Bayat A
Int J Surg; 2007 Aug; 5(4):278-85. PubMed ID: 17660136
[TBL] [Abstract][Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
